Celldex

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.

CEO

Anthony S. Marucci

CEOAnthony S. Marucci

Employees

186

Employees186

Headquarters

Hampton, New Jersey

HeadquartersHampton, New Jersey

Founded

1983

Founded1983

Employees

186

Employees186

CLDX Key Statistics

Market cap

1.54B

Market cap1.54B

Price-Earnings ratio

-7.33

Price-Earnings ratio-7.33

Dividend yield

—

Dividend yield—

Average volume

1.80M

Average volume1.80M

High today

$23.69

High today$23.69

Low today

$21.77

Low today$21.77

Open price

$21.92

Open price$21.92

Volume

1.12M

Volume1.12M

52 Week high

$47.00

52 Week high$47.00

52 Week low

$14.40

52 Week low$14.40

Analyst ratings

87%

of 15 ratings

Buy

86.7%

Hold

13.3%

Sell

People also own

Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.